澳华内镜收盘下跌2.86%，最新市净率4.72，总市值62.15亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Aohua Endoscopy, indicating a significant decline in revenue and net profit in the latest quarterly report [1] - As of March 31, 2025, Aohua Endoscopy had 4,022 shareholders, a decrease of 469 from the previous period, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company's main business involves the research, production, and sales of electronic endoscopy equipment and related medical consumables, with key products including endoscopy devices and maintenance services [1] Group 2 - Aohua Endoscopy's latest quarterly report for Q1 2025 shows a revenue of 124 million yuan, representing a year-on-year decline of 26.92%, and a net loss of approximately 28.79 million yuan, a year-on-year decrease of 1,143.36%, with a gross profit margin of 66.36% [1] - The company's price-to-earnings (PE) ratio is significantly negative at -589.71 (TTM) and -295.77 (static), with a price-to-book (PB) ratio of 4.72 and a total market capitalization of 6.215 billion yuan [2] - The industry average PE ratio is 49.84 (TTM) and 47.96 (static), with an average PB ratio of 4.65 and an average market capitalization of 10.643 billion yuan [2]